Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?

1 hour ago 1

Laiba Immad

Thu, June 25, 2026 astatine 7:40 AM CDT 2 min read

We precocious compiled a database of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Ocular Therapeuticx, Inc. (NASDAQ:OCUL) is among the best healthcare stocks.

TheFly reported connected June 18 that H.C. Wainwright accrued its terms people connected OCUL to $25 from $21 portion maintaining a Buy standing connected the stock. The firm's updated outlook followed the company's treatment of feedback received during a caller Type C gathering with the FDA astatine its capitalist time event. H.C. Wainwright indicated that the regulatory update strengthened assurance successful Axpaxli's commercialized potential, starring to higher projections for highest yearly gross and an improved appraisal of the therapy's likelihood of obtaining regulatory approval. The steadfast besides noted expectations for beardown doc uptake and wide marketplace penetration pursuing a imaginable launch.

Is Ormat Technologies, Inc. (ORA) The Best Alternative Energy Stock to Buy Now?

Is Ormat Technologies, Inc. (ORA) The Best Alternative Energy Stock to Buy Now?

A important firm improvement occurred connected June 17, erstwhile Ocular Therapeuticx, Inc. (NASDAQ:OCUL) outlined its regulatory strategy for AXPAXLI successful bedewed age-related macular degeneration. The institution announced plans to taxable a New Drug Application successful the 4th fourth of 2026 utilizing efficacy and information results from the SOL-1 proceedings alongside interim information findings from SOL-R. OCUL besides revised the SOL-R survey plan to proceed evaluating further endpoints done Week 96 and further differentiate AXPAXLI from existing treatments. In addition, the institution streamlined its non-proliferative diabetic retinopathy improvement programme by concentrating resources connected the Phase 3 HELIOS-3 trial.

Ocular Therapeuticx, Inc. (NASDAQ:OCUL) is simply a biopharmaceutical institution processing sustained-release therapies for retinal and oculus diseases, utilizing its proprietary hydrogel exertion to present medicine straight to the eye.

While we admit the imaginable of OCUL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article